🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study with low-dose LSD comprised 2 substudies in healthy subjects. Su...
Status
Completed
Location
PAREXEL, Early Phase Clinical Unit
Start Date
2015-10-20
Trial ID
NCT05674669
The aim of the study is to characterize the effects of low doses of LSD (d-...
Status
Completed
Location
University Psychiatric Clinics Basel
Start Date
2024-02-26
Trial ID
NCT05976698
A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-lab...
Status
Active Not Recruiting
Location
Preferred Research Partners, Inc.
Start Date
2025-01-29
Trial ID
NCT06809595
The purpose of this study is to determine the effects of very low doses of ...
Status
Completed
Location
Matthew Bona
Start Date
2018-05-01
Trial ID
NCT03790358
Treatments Being Tested
The investigators aim to investigate the role of the serotonin 2A receptor ...
Status
Not Yet Recruiting
Location
Clinical Pharmacology & Toxicology, University Hospital Basel
Start Date
2025-10-01
Trial ID
NCT07189299
Treatments Being Tested
This Phase 3 extension study will evaluate the long-term efficacy and safet...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01415427
Treatments Being Tested
The study will test the effect of dopamine, serotonin, and direct 5-HT2A re...
Status
Completed
Location
University Hospital Basel
Start Date
2017-02-01
Trial ID
NCT03019822
Treatments Being Tested
Lysergic acid diethylamide (LSD) is a classic serotonergic psychedelic acti...
Status
Completed
Location
Clinical Pharmacology & Toxicology, University Hospital Basel
Start Date
2022-10-24
Trial ID
NCT05175430
Treatments Being Tested
The acute subjective effects of serotonin (5-HT)2A receptor stimulation wit...
Status
Completed
Location
University Hospital Basel, Clinical Trial Unit
Start Date
2021-01-01
Trial ID
NCT04516902
Treatments Being Tested
This study was a Phase 1, double-blind, placebo-controlled, randomised stud...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-29
Trial ID
NCT04421105